Login / Signup
Feifei Qiu
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Poor Prognosis
Cell Therapy
Working Memory
Nk Cells
Top Venues
Cancer immunology research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Qunfang Zhang
,
Fang Zheng
,
Yuchao Chen
,
Chun-Ling Liang
,
Huazhen Liu
,
Feifei Qiu
,
Yunshan Liu
,
Hongfeng Huang
,
Weihui Lu
,
Zhenhua Dai
The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells.
Cancer immunology research
12 (5) (2024)
Qunfang Zhang
,
Fang Zheng
,
Yuchao Chen
,
Chun-Ling Liang
,
Huazhen Liu
,
Feifei Qiu
,
Yunshan Liu
,
Hongfeng Huang
,
Weihui Lu
,
Zhenhua Dai
The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells.
Cancer immunology research
12 (5) (2024)
Qunfang Zhang
,
Fang Zheng
,
Yuchao Chen
,
Chun-Ling Liang
,
Huazhen Liu
,
Feifei Qiu
,
Yunshan Liu
,
Hongfeng Huang
,
Weihui Lu
,
Zhenhua Dai
The TOPK inhibitor HI-TOPK-032 enhances CAR T-cell therapy of hepatocellular carcinoma by upregulating memory T cells.
Cancer immunology research
(2024)